ArticleWorld journal of gastroenterology2025
Expanding the role of endoscopic resection in esophageal gastrointestinal stromal tumors: Insights and challenges.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Defining the role of endoscopic resection for esophageal gastrointestinal stromal tumors.Journal of gastrointestinal oncology · 2026Article
- Retrospective study on clinical outcomes and safety evaluation of da Vinci robot-assisted laparoscopy and endoscopic cooperative for small gastric stromal tumors resection: preliminary single-center experience.Journal of gastrointestinal oncology · 2026Article
- Endoscopic resection of oesophageal gastrointestinal stromal tumours: Promise, pitfalls and the path forward.World journal of gastroenterology · 2025Article
- Performance of endoscopic submucosal dissection and submucosal tunneling endoscopic resection for esophageal submucosal tumors: A multicenter retrospective cohort study.Annals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While rare, esophageal gastrointestinal stromal tumors (GISTs) have higher malignant potential and are typically diagnosed at larger sizes compared to gastric GISTs. However, well-defined guidelines for their optimal management remain lacking. Most esophageal GISTs are surgically managed with enucleation, while esophagectomy is reserved for larger tumors. Recent advances in endoscopic techniques, such as endoscopic submucosal dissection and submucosal tunneling endoscopic resection (ER), have allowed for endoscopic removal of submucosal esophageal lesions, including GISTs. Xu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.